Professor Dr. Hans-Hilger Ropers
Hans-Hilger Ropers studied medicine in Freiburg and Munich. From 1984 to 1997, he headed the Institute for Human Genetics at the University of Nijmegen, The Netherlands, and in 1994, he became Director at the Max Planck Institute for Molecular Genetics (MPIMG) and Professor for Human Genetics at the Free University in Berlin, Germany. From 2008 and 2014, he also served as Secretary of the Biomedical Class of the (former Prussian) Berlin-Brandenburg Academy of Science (BBAW). Since 2014 he is Director emeritus (active) at the MPIMG as well as Clinical Geneticist and Senior Adviser at the Institute of Human Genetics, University of Mainz, Germany.
As MD and first-generation Board-Certified Clinical Geneticist, Hans-Hilger Ropers has a long-standing interest in the molecular elucidation, diagnosis, prevention and treatment of genetic disorders. In the 1980ies, he was an active member of the Gene Mapping Community, acting as Chromosome Chair and Co-Chair at all Human Genome Mapping Conferences between 1985 and 1993, and from 2003 to 2011, he served as Council and Program Committee member of the Human Genome Organization (HUGO).
In the early 1990ies, he and his coworkers were among the first to employ positional cloning strategies for systematically identifying the molecular causes of Mendelian disorders, with a focus on X-linked blindness, deafness and mental retardation. As members of the European X-linked Mental Retardation Consortium (*1995), they made seminal contributions to the elucidation and diagnosis of X-linked intellectual disability (XLID). Together with N. Tommerup (Copenhagen), they were also involved in the first systematic effort to characterize disease-associated balanced chromosome rearrangements; moreover, they were among the first to describe copy number variants in complex disorders other than ID. In 2004, when XLID turned out to be less common than previously thought, Hans-Hilger Ropers and his partner H. Najmabadi (Tehran) set out to study autosomal recessive forms of ID (ARID) in a systematic manner. By pioneering the use of SNP arrays for large-scale autozygosity mapping in consanguineous ARID families, they demonstrated that ARID is extremely heterogeneous. Another milestone was the early adoption of Next Generation Sequencing (NGS) techniques in 2007, which added a new dimension to the molecular elucidation of X-linked and autosomal ID.
Hans-Hilger Ropers was an early critic of the world-wide search for common genetic markers of complex diseases, which he characterized as futile and ‘a waste of time’ (FAZ, 2001). He was among the first to point out that for the vast majority of complex diseases, common genetic markers are unlikely to exist (Am. J. Hum. Genet. 2007), and he argued that genome research should focus on monogenic diseases instead (Dialogues in Clin. Neurosci. 2010; Max-Planck-Jahrbuch 2011). Later on, he repeatedly urged the German government to emulate the Genomics England project that had started in 2012 (BBAW 2013) and to implement next generation sequencing techniques into genetic health care (Ropers, Konrad-Adenauer-Stiftung (KAS) 2018; Arnold et al, KAS 2019).
Hans-Hilger Ropers is member of the Royal Dutch Academy of Sciences (since 2002) and the BBAW (since 2003), Honorary Member of the German Society of Human Genetics and recipient of its Medal of Honor (2009). In 2014 he received the Scientific Award of the European Organization for Rare Diseases (EURORDIS), and in 2015 he was awarded an honorary PhD by the University of Social Welfare and Rehabilitation, Tehran.
Selected original articles
Mol Psychiatry. 2019 Jul;24(7):1027-1039. Epub 2018 Jan 4.
Mol Psychiatry. 2016 Jan;21(1):133-48. Epub 2015 Feb 3.
Eur J Med Genet. 2015 Dec;58(12):715-8. Epub 2015 Oct 24.
Hum Mutat. 2014 Dec;35(12):1427-35.
Genome Med. 2013 Feb 5;5(2):11. eCollection 2013.
Am J Hum Genet. 2012 May 4;90(5):847-55. Epub 2012 Apr 26.
Nat Genet. 2009 May; 41(5):535-43. Epub 2009 Apr 19.
J Med Genet. 2008 Nov; 45(11):704-9. Epub 2008 Aug 19.
Am J Hum Genet. 2008 May;82(5):1158-64. Epub 2008 May 1.
Hum Mol Genet. 2008 Feb 1;17(3):458-65. Epub 2007 Nov 6.
Am J Hum Genet. 2007 Oct;81(4):792-8. Epub 2007 Aug 31.
Hum Mutat. 2007 Jul;28(7):674-82.
Hum Genet. 2007 Mar;121(1):43-8. Epub 2006 Nov 21.
BMC Bioinformatics. 2005 Apr 5;6:85.
Am J Hum Genet. 2005 Feb;76(2):227-36. Epub 2004 Dec 7.
Nat Genet. 2003 Dec;35(4):313-5. Epub 2003 Nov 23.
Nat Genet. 2000 Feb;24(2):167-70.
Nat Genet. 1999 Sep;23(1):25-31.
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2794-9.
Nat Genet. 1998 Aug;19(4):327-32.
Hum Mol Genet. 1996 Jul;5(7):1035-41.
Science. 1995 Feb 3;267(5198):685-8.
Science. 1993 Oct 22;262(5133):578-80.
Nat Genet. 1992 Jun;1(3):199-203.
Nature. 1990 Oct 18;347(6294):674-7.
Selected review articles
Trends Genet. 2014 Jan;30(1):32-9. Epub 2013 Oct 28.
Annu Rev Genomics Hum Genet. 2010;11:161-87.
Curr Opin Genet Dev. 2008 Jun;18(3):241-50. Epub 2008 Aug 28.
Nat Rev Genet. 2005 Jan;6(1):46-57.
Selected opinion papers and perspectives
J Community Genet. 2012 Jul; 3(3): 229–236. Published online 2012 Apr 1.
Dialogues Clin Neurosci. 2010 Mar; 12(1): 95–102.
Am J Hum Genet. 2007 Aug;81(2):199-207. Epub 2007 Jun 29.